- 专利标题： Methods of increasing endogenous erythropoietin (EPO)
-
申请号： US11406484申请日： 2006-04-17
-
公开(公告)号： US20060178317A1公开(公告)日： 2006-08-10
- 发明人: Stephen Klaus , Al Lin , Thomas Neff , Qingjian Wang , Volkmar Guenzler-Pukall , Michael Arend , Lee Flippin , Alex Melekhov
- 申请人： Stephen Klaus , Al Lin , Thomas Neff , Qingjian Wang , Volkmar Guenzler-Pukall , Michael Arend , Lee Flippin , Alex Melekhov
- 申请人地址： US CA South San Francisco
- 专利权人： FibroGen, Inc.
- 当前专利权人： FibroGen, Inc.
- 当前专利权人地址： US CA South San Francisco
- 主分类号： A61K38/04
- IPC分类号： A61K38/04 ; A61K31/4745
摘要：
The present invention relates to methods for treating erythropoietin-associated conditions by increasing endogenous erythropoietin in vitro and in vivo. Methods for treating, pretreating or preconditioning, or preventing erythropoietin-associated conditions are also included. Compounds for use in these methods are provided, as are methods of identifying such compounds.
信息查询
IPC分类:
